Sponsor pipeline

Jiangsu Hansoh Pharmaceutical Co., Ltd. clinical trial pipeline

Get alerts when Jiangsu Hansoh Pharmaceutical Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

  1. Minor
    2 trials marked Unknown by the registry's verification sweep

    Registry verification sweep

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-28 NCT07844967 A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of HS-10506 Phase 1 Recruiting
2026-09-23 NCT07836504 A Pharmacokinetic Study of HS-10504 in Participants With Hepatic Impairment and Normal… Phase 1 Not Yet Recruiting

Active trials by phase

Phase 1
33
Phase 1/2
5
Phase 2
4
Phase 3
10
Phase 4
2

Disease areas by active trials, top 10 of 20

Lung Cancer (16) · Non-Small Cell Lung Cancer (NSCLC) (15) · Psoriasis (3) · Breast Cancer (2) · Chronic Myeloid Leukemia (CML) (2) · Colorectal Cancer (2) · Diabetes (2) · Kidney Cancer (2) · Leukemia (2) · Obesity (2)

Get alerts when Jiangsu Hansoh Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free